Combination Antiangiogenic and Immunotherapy for Advanced Hepatocellular Carcinoma: Evidence to Date
1 1 download
|
Immunotherapy in HCC
|
29/09/2022
|
|
Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview
1 1 download
|
Immunotherapy in HCC
|
29/09/2022
|
|
Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment
1 1 download
|
Immunotherapy in HCC
|
29/09/2022
|
|
Combination Cancer Immunotherapy in Hepatocellular Carcinoma
1 1 download
|
Immunotherapy in HCC
|
29/09/2022
|
|
Novel immunotherapy combinations in clinical trials for hepatocellular carcinoma: will they shape the future treatment landscape?
1 1 download
|
Immunotherapy in HCC
|
29/09/2022
|
|
Clinically approved combination immunotherapy: Current status, limitations, and future perspective
1 1 download
|
Immunotherapy in HCC
|
29/09/2022
|
|
Immunotherapy for advanced hepatocellular carcinoma a focus on special subgroups
1 1 download
|
Immunotherapy in HCC
|
29/09/2022
|
|
Combination therapy for advanced hepatocellular carcinoma do we see the light at the end of the tunnel
1 1 download
|
Immunotherapy in HCC
|
29/09/2022
|
|
Advances in immunotherapy for hepatocellular carcinoma
1 1 download
|
Immunotherapy in HCC
|
29/09/2022
|
|
Immunotherapy for Hepatocellular Carcinoma: Current Status and Future Prospects
1 1 download
|
Immunotherapy in HCC
|
29/09/2022
|
|
Hepatocellular carcinoma
1 2 downloads
|
Immunotherapy in HCC
|
29/09/2022
|
|
Management of Hepatocellular Carcinoma in Japan JSH Consensus Statements and Recommendations 2021 Update
1 2 downloads
|
Guideline
|
29/09/2022
|
|
2022 Update of BCLC Treatment Algorithm of HCC: What’s New for Interventional Radiologists
1 1 download
|
Guideline
|
29/09/2022
|
|
Systemic treatment of hepatocellular carcinoma: An EASL position paper
1 1 download
|
Guideline
|
29/09/2022
|
|
APASL practical recommendations for the management of hepatocellular carcinoma in the era of COVID-19
1 1 download
|
Guideline
|
29/09/2022
|
|
ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
1 1 download
|
Guideline
|
29/09/2022
|
|
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
1 2 downloads
|
Guideline
|
29/09/2022
|
|